FDA investigating tramadol use in children

Posted in Latest News on November 23, 2015.

The FDA posted the following alert on use of tramadol for children ages 17 and younger:

FDA is investigating the use of the pain medicine tramadol in children aged 17 years and younger, because of the rare but serious risk of slowed or difficult breathing. This risk may be increased in children treated with tramadol for pain after surgery to remove their tonsils and/or adenoids. FDA is evaluating all available information and will communicate final conclusions and recommendations to the public when the review is complete.

Tramadol is not FDA-approved for use in children; however, data show it is being used “off-label” in the pediatric population. Health care professionals should be aware of this and consider prescribing alternative FDA-approved pain medicines for children.

For the full alert, go to the FDA’s website:http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm463499.htm



More Latest News

Imagineering the Future of Pharmacy Regulation
March 2, 2017

The boards of pharmacy will elect officers and members of the NABP Executive Committee, review and vote on NABP policies, and guide the direction of the Association Continue reading


Important Administrative Rule Update
February 17, 2017

Effective January 12, 2017 Florida Administrative Code, 64K-1.004 Management and Operation of Database has been amended requiring all pharmacies that DO NOT dispense controlled substances in or into this state submit a Notification of Exemption from Reporting (Form DH8016-PDMP). Exemptions … Continue reading